日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study

Mirvetuximab Soravtansine治疗铂耐药且叶酸受体α高表达的卵巢癌患者的疗效和安全性:SORAYA研究结果

Matulonis, Ursula A; Lorusso, Domenica; Oaknin, Ana; Pignata, Sandro; Dean, Andrew; Denys, Hannelore; Colombo, Nicoletta; Van Gorp, Toon; Konner, Jason A; Marin, Margarita Romeo; Harter, Philipp; Murphy, Conleth G; Wang, Jiuzhou; Noble, Elizabeth; Esteves, Brooke; Method, Michael; Coleman, Robert L

PARP Inhibitors in Clinical Use Induce Genomic Instability in Normal Human Cells

临床使用的PARP抑制剂会诱导正常人类细胞基因组不稳定

Ito, Shuhei; Murphy, Conleth G; Doubrovina, Ekaterina; Jasin, Maria; Moynahan, Mary Ellen

The Role of CDK4/6 Inhibition in Breast Cancer

CDK4/6抑制在乳腺癌中的作用

Murphy, Conleth G; Dickler, Maura N